Endocyte Inc. saw its shares fall nearly 7 percent Tuesday morning after the drug development firm announced that its application for U.S. approval of a cancer drug could be delayed another 10 months.
What are Zeke Turner's top five strategies for keeping his work week under 40 hours? Do you really need work e-mail on your smart phone? What's it like to take a company public? The real estate exec has answers.
Researchers suspect the sex hormone known to increase libido and musculature could also play a role in preventing a form of diabetes that tends to strike later in life and afflicts more than 330 million people worldwide.
The cost of health care for an additional 400,000 low income residents is something nobody in the Indiana Statehouse seems to be able to agree upon this year, even as the crucial decision about whether to expand Medicaid bears down on lawmakers midway through their annual session.
Decisions by other Republican governors to support Medicaid expansion is increasing pressure on Indiana’s governor to do the same.
Roche AG and Eli Lilly and Co., two drugmakers racing to develop treatments for some of the least understood brain disorders, may gain the most from a U.S. government boost in funding to fully map the human brain.
Community Health Network’s new partnership with Wishard Health Services will create a primary-care behemoth that the systems argue will put them in the best position possible to handle the changes coming from federal health reform.
The partnership will create a new board to oversee and coordinate the operations of both systems, according to internal messages sent to Community stakeholders. Community Health CEO Bryan Mills will be the CEO of the new joint-operating entity.
The health care systems would not provide details, but said the announcement would place "Indianapolis in the best position for health care reform."
A federal audit released Friday recommends Indiana's human services agency refund more than $5.8 million in Medicaid funds because Logansport State Hospital did not show it had complied with special conditions for psychiatric hospitals.
Indiana Gov. Mike Pence is asking the federal government to approve a three-year extension of the Healthy Indiana Plan health savings accounts in lieu of an expansion of a federal Medicaid system he calls "broken."
The Indianapolis-based health insurer saw its stock tumble as much as 4.8 percent Wednesday morning after it unexpectedly named career hospital executive Joe Swedish to be its next CEO.
The Indiana Senate Public Health Committee is advancing a proposal to expand Medicaid using the state's health savings account plan.
Eli Lilly said it is halting testing of experimental drug tabalumab because the studies show the medicine is not effective. The company said it expects to take a $50 million charge in the first quarter related to the research expenses from the drug.
Elona Biotechnologies Inc., which has been struggling to repay Greenwood for more than $8 million in economic development incentives, says it has solution to its financial problems.
Gov. Mike Pence said Wednesday that he has ruled out expanding Medicaid under the federal health care law unless Indiana gets approval to use state health savings accounts for the expansion.
In the era of health care reform, hospitals will face two new challenges: They will need to run higher-volume, lower-margin businesses, and they’ll be on the hook financially for what patients do even when they’re not receiving health care. Community Health Network’s new partnership with Walgreens’ Take Care Clinics is designed to help address both issues.
An Indiana Senate committee has backed tougher limits on quantities consumers may buy of cold medications that can be used to make methamphetamine.
Indianapolis-based Pearl Pathways, founded by two former Eli Lilly employees, plans to move into new space in March and add the jobs by 2016.
Shares of Zimmer Holdings Inc. have generated impressive returns of 23 percent in the past year and some 2013 product launches could juice those results even further. But the Warsaw-based maker of orthopedic implants is also the most-exposed company in its industry to two key elements of health care reform: the medical device tax and bundled payments.
